Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Breakthrough notions in Hematology and Transfusion Medicine
- globalhematology2020

About Conference

Allied Academics Publication is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. Established in the year 1997, the conferences provide a global platform for the attendees to showcase their research and services in front of many key players in the field.

We proudly announce the upcoming conference Global Hematology 2020 in RomeThe details as below:

Title: 5th International Conference on Clinical Hematology and Transfusion Medicine

Date & Venue: Feb 24-25, 2020 Rome, Italy

Theme: Breakthrough notions in Hematology and Transfusion Medicine

We are a globally recognized and trusted organization to provide unique scientific and business services through our Journals and we are expanding the functionality of our International conferences.

Our primary focus is to support original research work, share and exchange the ideas of authors from various institutions with the world. Our journals act as successful outlets for numerous scholars including teaching professors and researchers.

Meet the Global Inspiring Experts and Speakers at Allied Academies Conferences to talk about on new advances in the field of medical and engineering to improve e health and treatment and additional innovations. Our Conferences is not just to make a phase to exchange estimations to the enormous social occasion of individuals, yet also endeavor to spread focused and research advances in the clinical and physiological parts of various fields

Welcome Message

Success of Global Hematology 2019 has boosted our gusto to conduct another event in 2020. Hence we are honoured to welcome you to attend the “5th International Conference on Clinical Hematology and Transfusion Medicine” which is going to be held on 24-25 February, 2020 at Rome, Italy. Theme of the conference is Breakthrough notions in Hematology and Transfusion Medicines that incorporates prompt keynote presentations, Oral talks, Poster displays and Exhibitions.

Scientific Sessions

Hematology

  • Anaemia
  • Blood coagulation mechanism
  • Polycythaemia
  • Histiocytosis
  • Hematologic neoplasms
  • Sports Hematology

Vascular Blood Disorders

  • Thrombocytopenias
  • Henoch-Schönlein purpura
  • Osler-Weber-Rendu disease
  • Haemolytic-uraemic syndrome
  • Drug reactions
  • Steroid purpura
  • Senile purpura
  • Hlers-Danlos syndrome
  • Marfan syndrome
  • Osteogenesis imperfecta

Cardio-Oncohematology


  • Echocardiographic
  • Cardiotoxicity
  • Chemotherapy
  • Cancer Genomics

Hematology Case Reports

  • General Hematology
  • Pathology
  • Oncology
  • Lymphomas
  • Leukemias
  • Pediatric Hematology-Oncology
  • Pediatric Hemato-Cardiology

Hematology and Neurology


  • Seizures and epilepsy
  • Headaches
  • Developmental disorders
  • Brain tumors
  • Sleep disorders
  • Nerve and muscle diseases
  • Movement disorders
  • Metabolic diseases

Hematologic Cancers

  • Hodgkin and non-Hodgkin lymphoma
  • Myelogenous leukemia
  • Acute lymphocytic
  • Chronic lymphocytic
  • Multiple Myeloma

Blood Syndromes: Diagnosis and Treatment

  • Bone Marrow Transplantation
  • Hematopoietic stem cell therapy
  • Cord blood transplantation
  • Gene therapy
  • Chemotherapy
  • Radiation therapy

Organ Specific Cancer

  • Blood cancers
  • Skin cancer
  • Breast Cancer
  • Colorectal Cancer
  • Bone cancer
  • Paediatric cancers
  • Gynaecologic Cancers

Stem Cell Therapy

  • Brain and spinal cord injury
  • Neurodegeneration
  • Blood cell formation
  • Pancreatic beta cells
  • Orthopaedics
  • Wound healing
  • Infertility

Cord Blood Transplantation

  • Human Leukocyte Antigen (HLA) Matching
  • Graft-Versus-Host Disease
  • Diversity
  • Infectious Disease Transmission
  • Clinical Data
  • Engraftment
  • Storage
  • Research and Clinical Trials

Clinical Hematology

  • Anaemia
  • Leukopenia
  • Thrombocytopenia
  • Polycythemia
  • Leucocytosis
  • Thrombocytosis
  • Hereditary myeloid malignancies
  • Clonal Hematopoiesis
  • NK/T-cell lymphomas

Biomarkers in Hematology and Oncology

  • Genetic markers
  • Tumour markers
  • Cancer biomarkers
  • Diagnostic Biomarker
  • Biomarker Discovery

Diagnosis and Screening of Hematology

  • Hemochromatosis
  • Idiopathic thrombocytopenic purpura
  • Malaise
  • Bone marrow transplantation
  • Blood transfusion

Immunohematology

  • Transfusion related acute lung injury (TRALI)
  • Acute kidney failure
  • Antibody screening
  • Gel Testing
  • Pretransfusion testing module
  • Rh-sensitization

Hematology and Pharma Industry

  • Biological drugs
  • Generic drugs
  • Increased investments
  • Healthcare expenditures

Transfusion Medicines

  • Immunologic Reaction
  • Infection
  • Inefficacy
  • Sickle Cell Disease
  • Hemostasis
  • Thrombosis
  • Cellular Therapies


Pediatric Hematology

  •  Acanthocytosis
  • Cancer infection control
  • Thrombocytopenia in new-born
  • Systemic Disorders
  • Anisocytosis
  •  Congenital dyserythropoietic anaemia
  • Related Conference of Pediatrics

·

Market Analysis

Market Analysis Report

The scope of the worldwide Hematology market is expected to grow over the next few years owing to rising occurrences of blood disorders such as anaemia, malaria, and thalassemia, combined with increasing incidences of kidney ailments. In addition, the arrivals of high throughput Hematology analyzer will enhancement the market's growth. An increasing number of blood donations, especially from developed countries are necessitating the claim for Hematology analyzer. As blood donations continue to rise, the need to precisely analyse these samples will act as a major driving progress factor for the global Hematology analyzer market over the next few years.

The Hematology marketplace was esteemed at US$ 3,167.2 million in 2017 and foreseeable to range US$ 5,288.3 million by 2028 at a CAGR of 5.9% throughout the forecast period from 2018 to 2026.


The International Hematology Analyzer and reagent market is projected to index an impressive enlargement at 5.7 percent CAGR during 2018–2024, foresees Persistence Market Research (PMR). In 2017, the market was appraised at revenues worth USD 1433.43 million, and is estimated to surpass USD 2000 million by the end of 2024. By 2024, the six-part differential analysers segment is anticipated to touch USD 230 million on account of a high CAGR of 6.1 percent during 2018–2024.


The five-part disparity analyzers are appraised to remain sought-after products, with sales predictable to reach USD 1386.7 million by end of 2024. Three-part and five-part differential analyzers are expected to witness parallel expansion at 5.6 percent CAGR through 2024. Additionally, the standalone hematology analyzers will remain most-beneficial in the market, expanding at 5.8 percent CAGR through 2024. These analyzers are highly preferred among large-scale hospitals in developed economies. In addition, sales of PoC hematology analyzers are estimated to reach USD 929.2 million by the end of 2024.

At present, North America is the chief market for hematology analyzers. This market style can be endorsed to the increasing frequency of blood disorders. The increasing circumstances of blood-related disorders, such as anemia, blood cancer, etc., may lead to the progression of the hematology market. Europe is the second-prevalent market, while Asia-Pacific is the firmest growing region.



Global Hematology Societies:

Hematology Societies in USA:

American Cancer SocietyAmerican Brain Tumor AssociationAssociation of Community Cancer CentersAmerican Childhood Cancer OrganizationAmerican Society for Radiation OncologyInternational Society on Thrombosis and Haemostasis,Inc.,  Childhood Brain Tumor FoundationMichigan Society of Hematology and OncologyLymphoma Research FoundationThe Canadian Hematology SocietyAmerican Society of HematologyInternational Society for Laboratory Hematology,  Michigan society of HematologyAmerican Society of Clinical Oncology
 
European Hematology Societies:

International society of HematologyEuropean society of Hematology,  British Society of HematologyEuropean society of Pediatric Hematology OncologyEuropean Society of Surgical OncologyAssociation of European Cancer Leagues,  European Academy of Cancer SciencesEuropean Prostate Cancer CoalitionOrganization of European Cancer InstituteEuropean Organization for Research and Treatment of CancerInternational Society of Pediatric Oncology


Hematology Societies in South Africa:

CHOC Childhood Cancer FoundationAfrican Cancer Registry NetworkAfrican Journal of CancerMediterranean Oncology SocietySouth African Society of Haematology,  African Women’s Cancer Awareness AssociationHaematology and Oncology Society of Africa, World Health Organization Africa 
 
Hematology Societies in Asia-Pacific:

Asian Cancer FoundationAsia Pacific Hematology ConsortiumAsian Society of Gynecologic OncologyCancer Therapeutics Research GroupBlack Sea Countries Coalition on Breast and Cervical Cancer PreventionAsian Hematology Association, The Thai Society of HematologyAsian and Pacific Federation of Organizations for Cancer Research and ControlAsian Clinical Oncology Society: ACOSAsian Fund for Cancer ResearchAustralasian Lung Cancer Trials GroupJapanese Society of HematologyPan Arab Hematology Association




Join The Discussion

Allied Academies Global Conference Directory

Terms and Conditions

Responsibility

Delegates are personally responsible for their belongings at the venue. The Organizers will not be held responsible for any stolen or missing items belonging to Delegates, Speakers or Attendees; due to any reason whatsoever.


Insurance

Registration fees do not include insurance of any kind.


Transportation

Please note that any (or) all transportation and parking is the responsibility of the registrant.


Press/Media

Press permission must be obtained from Allied Academies Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied academies is a non-profit organization. This conference is not associated with any commercial meeting company.


Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference. Once your registration is complete, please contact hematologymeet@alliedglobalevents.com to request a personalized letter of invitation.

Regarding refunds, all bank charges will be for the registrant's account.

Cancellation, Postponement and Transfer of Registration

All cancellations or modifications of registration must be made in writing to Program Manager (hematologycongress@alliedevents.org)


Cancellation Policy.:

 

All cancellations or modifications of registration must be made in writing to finance@alliedacademies.com

If due to any reason, Allied academies postpone an event on the scheduled date, the participant is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within the period of one year from the date of rescheduling.

Our policy has been updated on October 1st, 2018.


Postponement

If Allied academies postpone an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies Conferences event which must occur within one year from the date of postponement.


Transfer of registration

All fully paid registrations are transferable to other persons from the same organization if registered person is unable to attend the event. Transfers must be made by the registered person in writing to Program Manager. Details must be included with the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of the conferences.

However, Registration cannot be transferred if it is intimated within 14 days of the respective conference.

The transferred registrations will not be eligible for Refund.



Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied Academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied Academies, including the inability to obtain a visa.


Refund Policy

If the registrant is unable to attend and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs:


  • Before 60 days of the conference: Eligible for Full Refund less $100 Service Fee
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.


Accommodation Cancellation Policy

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied Academies will advise the cancellation policy of your accommodation provider, prior to cancelling or amending your booking, to ensure you are fully aware of any non-refundable deposits.

Copyright © 2019-2020 Allied Academies, All Rights Reserved.